POTASSIUM CITRATE
- Product NDC
- 43602-400
- 11-digit product format
- 436020400
- Labeler code
- 43602
- Product ID
- 43602-400_e66721be-46fd-4d8b-a622-c357bb785e0f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Potassium Citrate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Ascent Pharmaceuticals Inc
- Application
- ANDA214420
- Marketing category
- ANDA
- Marketing start
- 2021-02-15
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM CITRATE
- Active strength
- 10 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43602-400 | POTASSIUM CITRATE TABLET, EXTENDED RELEASE [ASCENT PHARMACEUTICALS INC] | 4 | Legacy NDC | 20210219_e49f812c-74e2-4ee7-80d8-57f7f93fe02b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43602-400-05 | 43602040005 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-400-05) | 2021-02-15 | 0000-00-00 | No | No | Current |
| 43602-400-30 | 43602040030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-400-30) | 2021-02-15 | 0000-00-00 | No | No | Current |